These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1318698

  • 21. [A phase I study of carboplatin].
    Ogawa M, Imajo K, Horikoshi N, Inoue K, Mukaiyama T, Yamazaki H, Ueno K, Nakamura T, Aiba K, Kuraishi Y.
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1292-6. PubMed ID: 3034170
    [Abstract] [Full Text] [Related]

  • 22. Taxol in the treatment of lung cancer.
    Ettinger DS.
    J Natl Cancer Inst Monogr; 1993 May; (15):177-9. PubMed ID: 7912523
    [Abstract] [Full Text] [Related]

  • 23. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 24. Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.
    Smith IE, Harland SJ, Robinson BA, Evans BD, Goodhart LC, Calvert AH, Yarnold J, Glees JP, Baker J, Ford HT.
    Cancer Treat Rep; 1985 Jan; 69(1):43-6. PubMed ID: 2981620
    [Abstract] [Full Text] [Related]

  • 25. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
    Johnson DH, Paul DM, Hande KR, DeVore R.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
    [Abstract] [Full Text] [Related]

  • 26. [Pharmacological approach to the platinum compounds].
    Sasaki Y.
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):456-62. PubMed ID: 1313667
    [Abstract] [Full Text] [Related]

  • 27. [Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study].
    Reck M, Haering B, Koschel G, Kaukel E, von Pawel J, Gatzemeier U.
    Pneumologie; 1998 Oct; 52(10):570-3. PubMed ID: 9847635
    [Abstract] [Full Text] [Related]

  • 28. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
    Zhao Y, Wang SM, Zhang J.
    Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750
    [Abstract] [Full Text] [Related]

  • 29. [A phase II study of epirubicin in advanced lung cancer].
    Furuse K, Fukuoka M, Yamamoto M, Kawahara M, Tsuruta M, Kodama N, Arai R, Hayashi S, Kiyota M, Kubota K.
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2835-40. PubMed ID: 3019252
    [Abstract] [Full Text] [Related]

  • 30. A case report of pulmonary adenocarcinoma responding to (glycolato-0,0') diammineplatinum (II), a new platinum complex.
    Sasaki Y, Ohta T, Tamura T, Eguchi K, Shinkai T, Noguchi M, Saijo N.
    Jpn J Clin Oncol; 1987 Sep; 17(3):285-90. PubMed ID: 3312721
    [Abstract] [Full Text] [Related]

  • 31. Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
    Lorusso V, Gebbia V, Spada M, Guida M, Cassano G, Brunetti C, Germano D, Nettis G, Izzi G, Galetta D, Giampaglia M, Silvestris N, Colucci G.
    Oncol Rep; 2005 Dec; 14(6):1547-51. PubMed ID: 16273254
    [Abstract] [Full Text] [Related]

  • 32. [Pilot combination phase II study of mitomycin C plus cisplatin for non-small cell lung cancer].
    Shimizu E, Kamei T, Kimura K, Mukai J, Nakamura Y, Kunishige E, Fukuta K, Tani K, Sone S, Ogura T.
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3719-23. PubMed ID: 2556971
    [Abstract] [Full Text] [Related]

  • 33. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
    Konno K, Nagahama F, Nakai Y, Nakabayashi T, Hiraga Y, Takebe K, Tamura M, Oizumi K, Sato M, Ito T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671
    [Abstract] [Full Text] [Related]

  • 34. [Phase II study of carboplatin in cervical carcinoma].
    Noda K, Kato T, Ikeda M, Akiya K, Yajima A, Ueda G, Nishiya I, Takamizawa H, Terashima Y, Tsutsui F.
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3067-72. PubMed ID: 3056277
    [Abstract] [Full Text] [Related]

  • 35. Lack of nephrotoxicity of new oral platinum drug JM216 in lung cancer patients.
    Fokkema E, de Vries EG, Meijer S, Groen HJ.
    Cancer Chemother Pharmacol; 2000 Nov; 45(1):89-92. PubMed ID: 10647508
    [Abstract] [Full Text] [Related]

  • 36. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.
    Cavalli F, Jungi WF, Sonntag RW, Nissen NI, Holland JF.
    Cancer Treat Rep; 1979 Nov; 63(9-10):1599-603. PubMed ID: 227599
    [Abstract] [Full Text] [Related]

  • 37. [Early phase II clinical study of KW-2307 in patients with lung cancer. Lung Cancer Section in KW-2307 Study Group].
    Furuse K, Ohta M, Fukuoka M, Kurita Y, Kobayashi K, Hasegawa K, Kimura I, Fujii M, Yoshida S, Kitamura S.
    Gan To Kagaku Ryoho; 1994 May; 21(6):785-93. PubMed ID: 8185336
    [Abstract] [Full Text] [Related]

  • 38. Phase II study of carboplatin in small cell lung cancer.
    Tamura T, Saijo N, Shinkai T, Eguchi K, Sasaki Y, Sakurai M, Fujiwara Y, Nakano H, Nakagawa K, Minato K.
    Jpn J Clin Oncol; 1988 Mar; 18(1):27-32. PubMed ID: 2832635
    [Abstract] [Full Text] [Related]

  • 39. A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity.
    Dmitrovsky E, Seifter EJ, Gazdar AF, Tsai CM, Edison M, Brantley P, Veach SR, Batist G, Ihde DC, Mulshine JL.
    Am J Clin Oncol; 1990 Aug; 13(4):285-9. PubMed ID: 2165737
    [Abstract] [Full Text] [Related]

  • 40. Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancer.
    Fokkema E, Groen HJ, Bauer J, Uges DR, Weil C, Smith IE.
    J Clin Oncol; 1999 Dec; 17(12):3822-7. PubMed ID: 10577855
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.